Pouchitis usually feels like your pouch drifting back toward how your colitis used to feel, often more mildly: more trips than your settled normal, a stronger and more sudden urge to go, cramping or an ache low in the abdomen or pelvis, and more trips at night, building over a few days. The American Gastroenterological Association's 2024 guideline names exactly those as the typical symptoms: increased stool frequency, urgency, lower abdominal pain or cramping, and pelvic discomfort (Barnes 2024, AGA).
What it usually does not feel like matters just as much. Fever was absent in every patient in one of the classic diagnostic studies, and visible bleeding turned up in a different condition at the join rather than in pouchitis itself. That is the thread running through this article: what each sensation means, how typical it is in the research, what else can feel the same, and what happens next. If you are here because something feels off right now, the section on when to see a doctor promptly is at the end.
This is not a diagnostic guide. Even specialists cannot reliably tell pouchitis from its look-alikes by symptoms alone, which is why a pouch team usually wants to look. Where we say "we could find no study", that reflects our searching of PubMed and Europe PMC for this article, not proof that none exists.
What does pouchitis feel like? The short version
For most people, pouchitis feels like the pouch losing its calm: the count climbs, the urge arrives faster and harder, and there is a crampy, sore or pressured feeling low down. Many people describe it as a smaller echo of their old ulcerative colitis.
The AGA guideline on pouch disorders lists increased stool frequency, urgency, lower abdominal pain or cramping, and/or pelvic discomfort as typical, and states in the same breath that clinical symptoms of pouchitis do not necessarily correlate with what is seen on endoscopy or biopsy (Barnes 2024, AGA). The guideline was funded by the AGA Institute; several panel members report NIH grant support.
That matches what people with a pouch say among themselves. In one long-running r/UlcerativeColitis AMA, a person with a pouch since 2011 said their surgeon had told them consistent urgency was the most telling symptom, agreed that urgency was how they knew, and described pouchitis as milder than a UC flare and as having happened about three times in ten years (r/UlcerativeColitis AMA). Another AMA poster described two episodes that cleared within a day or so of starting treatment and did not stop them attending classes or driving (r/UlcerativeColitis AMA).
Not everyone has it that easy. One person in r/IBD described getting "deathly sick" with pouchitis once or twice a year and asked what could prevent it because it was interfering with work (r/IBD thread). Someone in r/ostomy described sharp, shooting pains roughly monthly; in that thread, another commenter described being treated for presumed pouchitis for a long time before their diagnosis was changed to Crohn's disease (r/ostomy thread). These are individual experiences, not evidence of how common each course is, but they show the range.
The honest summary: for many people an episode is an inconvenience that treatment settles quickly. For a minority it is frequent, painful and exhausting, and those are the people for whom it is most important that someone checks it really is pouchitis.
The first signs: how an episode usually starts
The first sign is usually a trend rather than a moment: your count drifting up over several days, urgency that does not ease after a good meal and a quiet evening, or waking to empty when you normally sleep through.
That is why every pouch team will ask what your normal is. The AGA guideline gives the expected range after the post-operative adjustment period as about 4 to 8 bowel movements a day and 1 to 2 a night (Barnes 2024, AGA), and our post on how many bowel movements a day are normal with a j pouch unpacks where those numbers come from and why your own settled number matters more than the average. Pouchitis shows up as a change from that number, not as a number in itself.
When does a first episode tend to happen?
Usually in the first year or two, but it can arrive much later.
- In a prospective series of 104 consecutive patients at a tertiary centre (97 with ulcerative colitis, 7 with familial adenomatous polyposis), half had at least one episode, and 56% of first episodes came within 12 months of the pouch being connected. Two first episodes came after 30 months (Hurst 1996).
- In one centre's review of 734 people followed for a mean of 41 months, the mean time to the first episode was 17 months (Lohmuller 1990).
- In insurance claims data on 594 people with UC, 48% were diagnosed with pouchitis within two years of surgery (Barnes 2021). Our before-surgery guide covers the incidence figures and how they have changed over time.
- People who had a pouch for familial adenomatous polyposis rather than colitis get it less often and later: in one tertiary centre's series of 113 such patients, 22.1% developed pouchitis, at a mean of 4.1 years (Quinn 2016).
What the very early weeks are not
In the first weeks after takedown, soreness, urgency, frequent small trips and mucus are common as the pouch and the muscles around it adapt. One person four weeks after their pouch surgery described constant soreness, mucus and extreme urgency with little output; the replies pointed toward ordinary adjustment and, in one case, a narrowing at the join, and the person had an appointment booked (r/ostomy thread). Our guide to what to expect after j pouch surgery covers the settling timeline. The pattern that should make you think of pouchitis is things getting worse after they had been getting better.
Symptom by symptom: how typical each one is
Each sensation has a different weight. Some are the core of pouchitis, some are unusual in it and point toward something else, and some are not about the pouch at all. The table summarises what the studies we read actually found.
| What you feel | How typical in pouchitis | What else it can point to |
|---|---|---|
| More trips than your usual | Core symptom; scored in the disease activity index | Irritable pouch syndrome, cuffitis, infection, diet, medicines |
| Urgency, cramping, lower abdominal pain | Core symptom; scored together as one item | Irritable pouch syndrome and cuffitis share it |
| Pelvic pressure or discomfort | Listed as typical by the AGA | Evacuation problems, a narrowing at the join |
| Visible blood | Uncommon in pouchitis in the studies we read | Cuffitis, inflammation at the join, other causes |
| Fever above 37.8°C | Scored item, but rare in the studies we read | Infection, abscess, other illness |
| Tiredness, feeling run down | Common in people with pouch symptoms generally | Anaemia, poor sleep, dehydration |
| Nausea or vomiting | Not among the typical symptoms | C. difficile infection; blockage if with cramps and little output |
| Joint, eye or skin symptoms | Associated with pouchitis in several studies | Extraintestinal manifestations running their own course |
Sources: Sandborn 1994, Barnes 2024, AGA, Shen 2002, Akiyama 2024, Gosai 2020, Lohmuller 1990.
More trips, and more urgency
This is the heart of it. The Pouchitis Disease Activity Index, developed at the Mayo Clinic in 1994 and still the research standard, scores symptoms, the endoscopic appearance and biopsy findings (Sandborn 1994). Its symptom part asks about four things: stool frequency compared with your usual, rectal bleeding, faecal urgency or abdominal cramps, and fever above 37.8°C (Akiyama 2024). Frequency is scored as one or two stools a day above your usual, or three or more above it, which is the index building in the same idea as this article: change from your own baseline.
Urgency and cramps sit together as one item. In the 61-patient study, increased frequency, urgency and abdominal cramps were the most common symptoms not only in pouchitis but in the two conditions it gets confused with (Shen 2002). So urgency is a good reason to suspect something has changed, and a poor way to tell which thing.
Is pouchitis painful?
Often, yes, but usually as cramping, a low ache or pelvic discomfort rather than sharp, severe pain. Cramping and lower abdominal pain are in the AGA's list of typical symptoms (Barnes 2024, AGA).
The descriptions people use vary: a gripping cramp before emptying, a sore or bruised feeling in the pelvis, a burning on the way out, pressure that does not go away after emptying. Some of those, especially burning around the anus, may be skin irritation from more frequent, looser output rather than the inflammation itself. If you are trying to put pain into words for a clinician, our guide on how to describe stomach pain to a doctor covers location, character and the scoring scales clinicians recognise.
Severe pain is a different matter. Constant or escalating pain, pain with vomiting, a swollen or rigid abdomen, or cramping with no output are not the typical pouchitis pattern and need prompt assessment, because obstruction and other complications can present that way.
Bleeding
Visible bleeding is less typical of pouchitis than most people assume. In that study, rectal bleeding was seen only in the people with cuffitis, inflammation of the short strip of rectal lining left at the join, and in none of those with pouchitis or irritable pouch syndrome (Shen 2002). The study was small: only four people had cuffitis. Our j pouch tracking guide sets out how the symptoms of pouchitis, cuffitis and irritable pouch syndrome overlap, so we will not rebuild that here.
The practical point is simple: blood is worth reporting whatever you think is causing it, and it is a clue your team will want to know about because it shifts the likely explanations.
Fever
Fever is in the scoring system, and it is rare in practice. In the 61-patient study, no one in any group had a fever (Shen 2002). In a 2024 Chicago analysis of 103 people with a pouch who had been scoped, only one person, whose inflammation was at the inlet of the pouch, had a recorded fever above 37.8°C; none of the seven with diffuse pouch inflammation did (Akiyama 2024). Those were symptom records from people being assessed, not continuous temperature monitoring, so mild fevers may have been missed.
That has a useful consequence. If you have a pouch and you feel feverish, with chills or rigors, do not assume it is "just pouchitis". A fever with pouch symptoms is a reason to contact your team the same day, because infection, an abscess or another illness needs to be considered. Our post on night sweats and fever in Crohn's disease explains why "feeling hot" and a measured fever are different things and why measuring matters.
Tiredness and feeling generally unwell
Fatigue is one of the most common things people with pouch problems report, and the research backs that up, with a caveat. In the Crohn's & Colitis Foundation's Partners cohort, 199 of 243 people with a pouch (82%) reported having had pouch symptoms at some point, and those with symptoms in the previous six months scored clearly worse on a standard fatigue measure (mean 56.3 versus 47.0) as well as on pain interference and depression (Barnes 2017). The authors judged these differences clinically meaningful. The caveat is that the study asked about pouch-related symptoms in general, not confirmed pouchitis. One author reported consulting for several drug companies; the others reported no relevant conflicts.
Several things could feed fatigue in an episode: broken sleep from night trips, fluid loss from extra output, and the inflammation itself. If tiredness persists, it is worth asking for a blood count and iron studies rather than writing it off.
Nausea
Nausea is not on the AGA's list of typical symptoms. Where it does show up in the research is in infection. In one hospital's review of 160 people admitted with pouchitis, 16 were diagnosed with C. difficile infection of the pouch, and of those 16, 13 (81%) had diarrhoea, 8 (50%) had abdominal pain, 7 (44%) had nausea or vomiting and 2 (13%) had bleeding (Gosai 2020). These were inpatients, so they are sicker than most people with an episode at home. Nausea with pouch symptoms is a reasonable prompt to ask whether infection has been tested for.
Joint pain, and other symptoms outside the gut
Pouchitis and joint pain can travel together. In the 734-person series, pouchitis was more common in those who had had extraintestinal manifestations of IBD before surgery (39% versus 26%) and after it (53% versus 25%). Among 12 people with pouchitis whose symptoms outside the gut had resolved after surgery and then returned, in 7 those symptoms came back when pouchitis flared and settled when it was treated (Lohmuller 1990).
Later work supports the association. A 2019 meta-analysis of 22 observational studies covering 5,128 patients found extraintestinal manifestations were associated with pouchitis overall (odds ratio 1.96) and chronic pouchitis (odds ratio 2.28) (Hata 2019), and a 2024 state-level cohort of 177 people found the same within the first year after surgery (adjusted odds ratio 2.45), alongside a family history of IBD (adjusted odds ratio 3.50) (Barnes 2024, CTG). These are associations, not proof that pouchitis causes joint pain, and both directions could reflect the same underlying immune tendency.
Low back pain is a common search alongside pouchitis. We could find no study measuring back pain as a pouchitis symptom. Inflammatory back pain in IBD is usually a separate problem involving the sacroiliac joints and spine, which our explainer on joint pain and other symptoms outside the gut in IBD covers, including when to ask for a rheumatology opinion.
Why it feels the way it does
Pouchitis is inflammation of the lining of the pouch, the reservoir your surgeon built from the end of your small intestine. In the 734-person series, its features resembled those of IBD closely enough that the authors suggested pouchitis may be a new form of the original disease persisting after the operation (Lohmuller 1990). Inflamed lining is more sensitive and handles fluid differently, which fits the frequency, urgency and cramping people feel.
One intuitive explanation does not hold up well, though. It is tempting to think an inflamed pouch simply becomes stiffer and holds less. A review of 141 pouch compliance tests, which measure how much a pouch stretches as it fills, found no difference in compliance between people with an identifiable problem such as pouchitis, pelvic infection or a narrowing at the join, and people whose pouch dysfunction had no clear cause (Maeda 2010). That study did not compare inflamed pouches with healthy ones, so it cannot rule the idea out. It does suggest the feeling of a pouch that "cannot hold anything" is not simply a measurable loss of capacity.
The deeper lesson is the one the research keeps repeating: the strength of the symptoms and the degree of inflammation do not line up neatly. That is why the AGA guideline says symptoms do not necessarily correlate with what is seen on a scope (Barnes 2024, AGA), and why a bad week can be inflammation, or no inflammation at all.
Is it pouchitis, or something that feels the same?
Often you cannot tell from the inside, and the research says your doctor cannot reliably tell from symptoms either. In the study of 61 people with pouch symptoms, about half had pouchitis, a few had cuffitis, and 42.6% had no inflammation at all, a pattern the authors named irritable pouch syndrome (Shen 2002). Our j pouch tracking guide covers that study and the related work in detail, including which logged patterns point toward which condition, so here we focus on the look-alikes it does not dwell on.
C. difficile infection of the pouch
C. difficile can infect a pouch and produce symptoms that look like pouchitis, and it is tested for with a stool sample. How often it turns up depends heavily on who is tested:
- At one tertiary IBD centre, 11 of 154 symptomatic pouch patients who were tested (7.1%) had it, a median of 139 days after the final operation; 10 of the 11 reported improvement with treatment (Kayal 2020). The authors reported no conflicts of interest.
- In 198 people with chronic antibiotic-dependent pouchitis or Crohn's-like disease of the pouch at another centre, 18 (9.1%) developed it. Two thirds of those who developed it had had C. difficile before their pouch surgery, compared with 6% of those who did not (Shore 2023). Several authors reported consulting relationships with drug and microbiome companies.
- In a US national inpatient database, 2.5% of 3,566 people admitted with pouchitis had a C. difficile diagnosis recorded (Kistangari 2017).
Medicines, especially NSAIDs
Regular anti-inflammatory painkillers such as ibuprofen and naproxen are linked to pouch inflammation. In a cohort of 17 people seen in a pouchitis clinic with pouch problems who had taken NSAIDs daily for more than six months, stopping them was followed by a fall in the mean disease activity score of 3.6 points and better quality-of-life scores over four weeks (Shen 2007). It was a small study with no comparison group, and most participants had chronic refractory pouchitis. If you take NSAIDs regularly, tell your team; do not stop or change a prescribed medicine without talking to them first.
Crohn's-like disease of the pouch
A minority of people who had a pouch for ulcerative colitis later develop inflammation that behaves like Crohn's disease, with fistulas, strictures or inflammation above the pouch. The AGA estimates around 10% (Barnes 2024, AGA). Pain around the anus with discharge, a new lump or opening near the anus, or symptoms that keep returning despite treatment are reasons to raise this. The before-surgery guide covers why people get told their diagnosis "turned into Crohn's".
Ordinary things
A stomach bug, a big late meal, a new medicine, travel or a run of poor sleep can all shift your pouch for a day or two. One AMA poster said their first "episode" followed norovirus (r/UlcerativeColitis AMA). The difference with pouchitis is usually persistence: an ordinary disturbance settles within a day or two, while an episode tends to keep building.
How is pouchitis diagnosed? Is it scoped every time?
Pouchitis is formally diagnosed by combining symptoms with a look inside the pouch. The scored version of that, the full disease activity index, adds a biopsy; a score of 7 or more out of 18 counts as pouchitis (Shen 2003). When it was introduced, all 10 people with clinical pouchitis in the original small study met the new criteria, compared with only 1 of the 10 under the scoring systems used before it (Sandborn 1994).
Because biopsies cost time and money, the same research group tested dropping them. In 58 people with symptoms, symptoms plus endoscopy alone, the "modified" index, matched the full index almost perfectly: with a cut-off of 5, sensitivity was 97% and specificity 100% (Shen 2003). That is why a scope through the anus into the pouch, often called a pouchoscopy, is the central test rather than a biopsy result.
Is that done every time? Not necessarily. The AGA panel felt routine pouchoscopy is not always needed before treating typical, infrequent episodes that respond to the usual treatment, and that a scope is warranted for frequent recurrences, poor response, atypical symptoms or suspected Crohn's-like disease (Barnes 2024, AGA). The tracking guide covers how your records help your team make that call, and what calprotectin can and cannot add.
A score is also not the last word. In a study of 70 people followed after surgery, 21 had symptoms but scored below the pouchitis cut-off, and 12 of those still improved with antibiotics (Kohyama 2009). In other words, a "negative" score does not prove nothing is wrong, and response to treatment is itself part of how clinicians read the picture.
What about a stool test? A stool sample can look for infection such as C. difficile, and a calprotectin test can suggest inflammation. Neither on its own diagnoses pouchitis. In one r/ostomy thread, a commenter said pouchitis is "specifically caused by a bacterial infection" and can be diagnosed with a stool sample (r/ostomy thread). That is a common misunderstanding, addressed in the myths section below.
How quickly does it feel better with treatment?
For a typical acute episode, usually within days. Treatment decisions belong to your team, and this section describes what studies observed, not what anyone should take.
- In a small randomised trial, acute pouchitis was defined as a high disease activity score with symptoms lasting four weeks or less, and both antibiotics tested lowered the score over two weeks (Shen 2001). The Cochrane review's re-analysis of that trial found all 7 people on one antibiotic and 3 of 9 on the other reached remission at two weeks, which it rated as very low certainty evidence because the trial was so small (Nguyen 2019).
- In the 104-patient series, 96% of people responded to antibiotics, judged by resolution of symptoms (Hurst 1996). In the 61-patient study, 27 of 31 people with confirmed pouchitis (87.1%) responded to a two-week course (Shen 2002).
- In a large health-records network, the choice between the two commonly used antibiotics made no significant difference to early relapse or later recurrence (Barnes 2023).
People in pouch threads commonly describe feeling better within a day or two of starting treatment (r/UlcerativeColitis AMA). That is a fair reflection of the research for typical episodes. If you are not clearly improving partway through a course, tell your team rather than waiting for the end of it, because poor response is one of the triggers for a closer look.
Can pouchitis go away on its own?
Sometimes, but the evidence on how often is thin and comes from a handful of small trials.
Start with the guideline. The AGA's definition of intermittent pouchitis explicitly includes episodes that resolve "with therapy (most commonly, antibiotics) or spontaneously" (Barnes 2024, AGA). For its statistical analysis, the panel needed a placebo rate for studies that had no placebo group, and it assumed a spontaneous improvement rate of 40% (range 30% to 50%) for infrequent episodes and 30% (range 20% to 40%) for chronic pouchitis, saying these were comparable to response rates in placebo arms of IBD trials and the few pouchitis trials published. That is an assumption used for modelling, not a measured rate in people with an untreated first episode. We could find no study that followed acute pouchitis without treatment.
The placebo groups in randomised trials, all small, show the same split between "improved" and "gone":
| Trial (people on placebo) | Type of pouchitis | Improved clinically | Reached remission |
|---|---|---|---|
| Rifaximin trial, 4 weeks (10) | Acute | 3 of 10 | 0 of 10 |
| Bismuth foam enema trial, 3 weeks (20) | Chronic | 9 of 20 | not reported in the review abstract |
| Adalimumab trial, 4 weeks (7) | Chronic | 3 of 7 | not reported in the review abstract |
| Lactobacillus GG trial, 12 weeks (10) | Acute | 0 of 10 | not reported in the review abstract |
| Vedolizumab trial, 14 weeks, all also given an antibiotic for the first 4 weeks (51) | Chronic | not reported here | 5 of 51 (10%) |
Sources: Nguyen 2019, Cochrane for the first four rows; Travis 2023 for the vedolizumab trial, which was funded by the drug's manufacturer, Takeda. The Cochrane authors rated almost all of this evidence low or very low certainty; two of its authors report consulting fees or research grants from several drug companies.
And in a small crossover trial of 13 people with chronic, unremitting pouchitis, stool frequency rose by a median of one a day on placebo, while it fell by a median of three on the antibiotic. Notably, symptom scores, endoscopy and blood markers did not change significantly in that trial (Madden 1994).
So the fair answer is: some people's symptoms ease without active treatment, roughly a third to a half of placebo groups in three of these trials, but full remission without treatment was rare, and the only placebo data in acute pouchitis come from two trials with 10 people on placebo each. We could find no study of what happens to an untreated first episode. Mild symptoms that settle within a day or two are common and are not necessarily pouchitis. Symptoms that persist beyond a few days, or keep worsening, are a reason to contact your team rather than wait.
Does having pouchitis once mean it will keep coming back?
Often it comes back at least once, but how often depends heavily on how "came back" is measured. Here is the spread, with the method behind each figure:
| Study | Who | How recurrence was counted | Finding |
|---|---|---|---|
| Hurst 1996 | 104 consecutive patients, one tertiary centre | Symptoms confirmed by endoscopy | Two thirds of people with pouchitis had multiple episodes; 6 developed chronic pouchitis |
| Lohmuller 1990 | 734 patients, one surgical centre | Clinical records | Recurred in 61% of those at risk |
| Barnes 2021 | 594 people with UC, insurance claims data | Diagnosis and prescription codes, first 2 years | 48% had pouchitis: 29% isolated, 19% recurrent |
| Barnes 2023 | 271 people treated for a first episode, global health-records network | Any relevant antibiotic prescription 4 weeks to 12 months after the first episode | 190 (70%) classed as recurrent |
| Quinn 2016 | 25 people with pouchitis after surgery for polyposis | Clinical records | 72% acute course, 28% chronic |
Some factors are linked with a higher chance of pouchitis, including symptoms of IBD outside the gut and primary sclerosing cholangitis (Hata 2019; Barnes 2021). The AGA estimates that around 17% of patients develop chronic symptoms of pouchitis (Barnes 2024, AGA). So the realistic message after a first episode is: more episodes are likely, a chronic course is possible, and most people do not end up there.
What chronic pouchitis feels like
Chronic pouchitis feels less like an episode and more like a pouch that will not settle: symptoms that return within days or weeks every time treatment stops, or that never fully go away. The AGA uses two working definitions (Barnes 2024, AGA):
- Chronic antibiotic-dependent pouchitis: episodes respond to antibiotics but relapse shortly after stopping, typically within days to weeks, often needing repeated or continuous treatment.
- Chronic antibiotic-refractory pouchitis: relapsing or continuous symptoms that do not respond adequately to the usual antibiotics.
The guideline deliberately did not set a number of episodes per year, calling it a continuum: some people need three or four courses a year, others need antibiotics almost continuously. Some patient-information pages give a fixed cut-off such as "more than three relapses a year"; the AGA panel chose not to.
What this is like to live with comes through in the threads. One person with a pouch for 14 years described chronic pouchitis since it was created, waking about four times a night despite antibiotics, diet changes and other measures, and as often as six to nine times with a cold, and was weighing a permanent ileostomy mainly for sleep (r/ostomy thread). Another described being hospitalised with severe joint pain, rash, aches and fever alongside severe pouch inflammation, and weight loss despite eating (r/UlcerativeColitis thread).
The evidence on chronic pouchitis shows why it is hard. In two probiotic maintenance trials pooled by Cochrane, only 1 of 36 people on placebo stayed in remission over 9 to 12 months after antibiotics had settled them, compared with 34 of 40 on the probiotic formulation, though the certainty was rated low (Nguyen 2019). Real-world experience was less encouraging than those trials: in a series of 31 people with antibiotic-dependent pouchitis, all responded to a two-week antibiotic course, but only 6 were still on the probiotic and in remission at 8 months, the rest having stopped because of recurrence or side effects (Shen 2005). For more resistant disease, the vedolizumab trial found remission at 14 weeks in 31% on the drug versus 10% on placebo (Travis 2023), a real difference that still left most people on the drug not in remission at that point.
None of that is a reason for despair. In the claims data, only 1.0% of people with pouchitis had their pouch removed within two years (Barnes 2021). It is a reason to push for a proper work-up, including infection, medicines and Crohn's-like disease, if your pouch keeps flaring, rather than accepting repeat antibiotics indefinitely without anyone looking.
Clairop logs meals, symptoms and stool in seconds, then looks for the foods your gut reacts to, including reactions that land days later.
What to note when you think an episode is starting
A few specific notes make the conversation with your team much faster, and they are exactly the details the scoring systems ask about. The full method, including how to set a baseline and log each antibiotic course, is in our guide to tracking symptoms with a j pouch. The short list for an episode:
- The date it started, and whether it came on over days or suddenly.
- Your daytime and night-time counts compared with your settled normal, because the index scores the difference.
- Urgency and cramps, and where any pain is: lower abdomen, deep in the pelvis, or around the anus.
- A measured temperature, not just feeling hot, since true fever is unusual and changes the urgency.
- Any blood, and whether it is on the paper, in the bowl or mixed in.
- Anything that might explain it: a stomach bug in the household, a new medicine, regular NSAIDs, a recent course of antibiotics, travel.
- Symptoms outside the gut, such as joint pain, red or painful eyes, or new skin lesions.
If you prefer to keep this on your phone, Clairop lets you log symptoms quickly, by voice if typing feels like too much, and builds a one-page summary of your bowel pattern to take to your appointment. You can see how it works on the how it works page. A notebook does the same job; what matters is that the counts are written down at the time, not remembered a week later.
Myths worth dropping
"Pouchitis is a bacterial infection, so a stool test will show it." Pouchitis is inflammation of the pouch lining. Bacteria are thought to be involved, which is why antibiotics often help, but it is not an infection with a single germ that a stool test detects. Stool tests look for specific infections such as C. difficile, which can cause or complicate pouch symptoms (Kayal 2020). Pouchitis itself is confirmed by symptoms plus endoscopy (Shen 2003).
"If it were pouchitis, I would have a fever." Fever is part of the scoring system, but in the diagnostic studies we read it was almost never present (Shen 2002; Akiyama 2024). Its absence does not rule pouchitis out. Its presence is a reason to call your team.
"Bleeding means pouchitis." In the study that looked, visible bleeding pointed to cuffitis rather than pouchitis (Shen 2002). Bleeding should always be reported, but it does not identify the cause.
"Every bad pouch week is pouchitis." About four in ten people with pouch symptoms in one study had no inflammation at all (Shen 2002). Treating every bad week with antibiotics risks side effects without benefit.
"One episode means you will get chronic pouchitis." Most people with pouchitis do not develop a chronic course. In the series we read, chronic pouchitis affected a minority, around 17% by the AGA's estimate (Barnes 2024, AGA).
"Pouchitis means the pouch is failing." In insurance claims data, only 1.0% of people with pouchitis had their pouch removed within two years (Barnes 2021). Pouchitis and pouch failure are different things, although in the oldest series the small number with chronic pouchitis did face a real risk of pouch loss (Hurst 1996).
When to see a doctor promptly
Contact your pouch team or GI doctor if your counts, urgency or cramping have been clearly above your normal for more than a few days, if you keep relapsing soon after treatment, or if you are not improving partway through a course.
See a doctor promptly, the same day or via urgent care, if you have:
- a measured fever, chills or rigors with pouch symptoms;
- more than a small amount of blood, or any bleeding with dizziness, fainting or a racing heart;
- severe, constant or worsening abdominal pain, a swollen or tense abdomen, or vomiting;
- cramping with little or no output, especially with vomiting, which can signal a blockage;
- signs of dehydration: very dark or little urine, dizziness on standing, unusual thirst, confusion;
- new pain, swelling or discharge around the anus, or a new opening near it;
- unexplained weight loss, or symptoms that keep you up most of the night for days.
If you feel very unwell, faint, or confused, call emergency services. Dehydration can build quickly without a colon, and a pouch problem is not something to sit out at home when you are getting worse.
The honest bottom line
Pouchitis usually feels like a change in your own pouch pattern: more trips, more urgency, cramping or pelvic discomfort and more night-time waking, building over days and often easing within days of treatment. Fever and visible bleeding are unusual in it and point toward other problems. Because irritable pouch syndrome, cuffitis, infection and medicines can all feel the same, the feeling cannot confirm it; your team, usually with a scope, does that.
Some episodes settle by themselves, but the evidence on how often is thin and comes from a handful of small trials. Many people have more than one episode, and a minority develop chronic pouchitis, which deserves a proper work-up rather than endless repeat courses. Know your normal, write down when things change, and call early rather than late.
